Carregant...
5-HT(1F) receptor agonists: A new treatment option for migraine attacks?
Migraine is a debilitating disorder of the CNS. Although therapeutic options for migraine attacks have tremendously advanced with the development of triptans more than a decade ago, several conditions (such as vascular disease) restrict their use. Moreover, some patients do not respond to triptans a...
Guardat en:
| Publicat a: | Neurotherapeutics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer-Verlag
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084098/ https://ncbi.nlm.nih.gov/pubmed/20430316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2010.03.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|